Add to my calendar2019-05-16 18:30:002019-05-16 22:00:00New Advances in Diabetes Management: A Perspective from the Latest Cardiovascular Data in Type 2 Diabetes
Time: Arrivals 6:30 pm to 7 pm, Presentation 7 pm to 8 pm
Presenter: Dr. Sara Stafford, MDCM and FRCPC - Fraser Health Division of Endocrinology Clinical Instructor, University of British Columbia
Kindly RSVP to: Dayna Saari at 250-717-7417 or dysa@novonordisk.com
Learning Objectives
Describe the cardiovascular (CV) outcome benefits of GLP-1 RAs in patients with type 2 diabetes mellitus (T2DM)
Discuss practical strategies to incorporate GLP-1 RA therapies into clinical practice
Evaluate the latest advancements in basal insulin therapy and where they fit in high risk CV patients
This event is sponsored by Novo Nordisk Canada Inc. and is an unaccredited learning activity.
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.
The Keg Restaurant
582 George Street
Prince George V2L 1R7
Canada
Physician Educationphysician.education@northernhealth.caAmerica/Vancouverpublic
Add to Calendar: Start date2019-05-16 18:30:002024-04-18 02:33:40TitleDescriptionLocationPhysiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Add to Calendar: End Date2024-04-18 02:33:402019-05-16 22:00:00New Advances in Diabetes Management: A Perspective from the Latest Cardiovascular Data in Type 2 Diabetes
New Advances in Diabetes Management
The Keg Restaurant
582 George Street
Prince George V2L 1R7
Canada
Physiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Time: Arrivals 6:30 pm to 7 pm, Presentation 7 pm to 8 pm
Presenter: Dr. Sara Stafford, MDCM and FRCPC - Fraser Health Division of Endocrinology Clinical Instructor, University of British Columbia
Describe the cardiovascular (CV) outcome benefits of GLP-1 RAs in patients with type 2 diabetes mellitus (T2DM)
Discuss practical strategies to incorporate GLP-1 RA therapies into clinical practice
Evaluate the latest advancements in basal insulin therapy and where they fit in high risk CV patients
This event is sponsored by Novo Nordisk Canada Inc. and is an unaccredited learning activity.
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.
Address:
The Keg Restaurant 582 George Street Prince GeorgeV2L 1R7 Canada
